Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 5/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | AR | P10275 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | HTR6 | P50406 | 1/20 | 0.50 |
| ▸ | ESRRG | P62508 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | BAX | Q07812 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bisphenol A SCHEMBL811003 | 0.98 | ESR1 (0.59) | ESR1ESR2ALDH1A1CYP3A4AR | |
| SCHEMBL3693240 | 0.94 | SRC (0.52) | ESR1ESR2ALDH1A1CYP3A4KDM4E | |
| SCHEMBL1900143 | 0.90 | ALDH1A1 (0.50) | ESR1ESR2ALDH1A1CYP3A4KDM4E | |
| SCHEMBL7193822 | 0.90 | ESR1 (0.50) | ESR1ESR2ALDH1A1CYP3A4AR | |
| SCHEMBL12670502 | 0.89 | ALDH1A1 (0.48) | ESR1ESR2ALDH1A1CYP3A4TSHR | |
| SCHEMBL811002 | 0.89 | ESR1 (0.59) | ESR1ESR2ALDH1A1CYP3A4AR | |
| SCHEMBL14023390 | 0.89 | ESR1 (0.59) | ESR1ESR2ALDH1A1CYP3A4AR | |
| Bisphenol A SCHEMBL1610315 | 0.89 | SRC (0.61) | ESR1ESR2ALDH1A1CYP3A4AR | |
| SCHEMBL6544825 | 0.89 | ALDH1A1 (0.48) | ESR1ESR2ALDH1A1CYP3A4KDM4E | |
| Bisphenol A SCHEMBL30608531 | 0.88 | ESR1 (0.51) | ESR1ESR2ALDH1A1CYP3A4AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110212179-A1 | MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME | LIU DAVID | 2011-09-01 | — | — | US | claimed |
| EP-2344578-A2 | MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME | Liu, David (US) | 2011-07-20 | — | — | EP | claimed |
| WO-2010062678-A2 | MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME | LIU DAVID (US) | 2010-06-03 | — | — | WO | claimed |
| US-20240209206-A1 | Flame Retardant Polycarbonate Composition With High Comparative Tracking Index | COVESTRO DEUTSCHLAND AG (DE) | 2024-06-27 | — | — | US | disclosed |
| US-11826951-B2 | Temperature-controlled multi-material overprinting | CELLINK AB (SE) | 2023-11-28 | — | — | US | disclosed |
| US-20220177497-A1 | CONTINUOUS INDUSTRIAL PRODUCTION METHOD OF HIGH-PURITY BISPHENOL A-BIS(DIPHENYL PHOSPHATE) | Zhejiang Wansheng Co.,Ltd (CN) | 2022-06-09 | — | — | US | disclosed |
| US-20210069964-A1 | TEMPERATURE-CONTROLLED MULTI-MATERIAL OVERPRINTING | BICO GROUP AB (SE) | 2021-03-11 | — | — | US | disclosed |
| EP-2010597-B1 | POROUS POLYMER BLEND STRUCTURES | UNIV QUEENSLAND (AU) | 2015-06-17 | — | — | EP | disclosed |
| WO-2012094708-A1 | BONE GRAFT BIOMATERIAL | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-07-19 | — | — | WO | disclosed |
| US-8222308-B2 | Porous polymer structures | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-07-17 | — | — | US | disclosed |
| US-8044108-B2 | Porous polymer blend structures | THE UNIVERSITY OF QUEENSLAND (AU) | 2011-10-25 | — | — | US | disclosed |
| EP-1173235-A1 | POROUS POLYMER SCAFFOLDS FOR TISSUE ENGINEERING | Rutgers, The State University (US) | 2002-01-23 | — | — | EP | disclosed |
| US-6337198-B1 | A BIODEGRADABLE AND BIOCOMPATIBLE POROUS POLYMER USED IN TISSUE ENGINEERING AND REGENERATION; THE POLYMER HAS A HIGHLY INTERCONNECTED BIMODAL DISTRIBUTION OF OPEN PORE SIZES, HIGH INTERNAL SURFACE AREA, LINEAR ALIGNED PORES ALONG THE WALLS | RUTGERS, THE STATE UNIVERSITY | 2002-01-08 | — | — | US | disclosed |
| WO-2000062829-A1 | POROUS POLYMER SCAFFOLDS FOR TISSUE ENGINEERING | RUTGERS, THE STATE UNIVERSITY (US) | 2000-10-26 | — | — | WO | disclosed |
| US-6103255-A | Porous polymer scaffolds for tissue engineering | RUTGERS, THE STATE UNIVERSITY (US) | 2000-08-15 | — | — | US | disclosed |
| EP-0990008-A1 | SOLUTION POLYMERIZATION OF HIGH MOLECULAR WEIGHT POLY(PHOSPHOESTERS) IN TOLUENE | GUILFORD PHARMACEUTICALS INC. (US) | 2000-04-05 | — | — | EP | disclosed |
| US-6028163-A | Solution polymerization of high molecular weight poly(phosphoesters) in toluene | GUILFORD PHARMACEUTICALS INC. (US) | 2000-02-22 | — | — | US | disclosed |
| US-5952451-A | Solution polymerization of high molecular weight poly(phosphoesters) in toluene | GUILFORD PHARMACEUTICALS INC. (US) | 1999-09-14 | — | — | US | disclosed |
| WO-1999000446-A9 | SOLUTION POLYMERIZATION OF HIGH MOLECULAR WEIGHT POLY(PHOSPHOESTERS) IN TOLUENE | GUILFORD PHARM INC (US) | 1999-05-06 | — | — | WO | disclosed |
| WO-1999000446-A1 | SOLUTION POLYMERIZATION OF HIGH MOLECULAR WEIGHT POLY(PHOSPHOESTERS) IN TOLUENE | GUILFORD PHARMACEUTICALS INC. (US) | 1999-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110212179-A1 | MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME | CD68, KIT, ARG2 | ESR1 4037/4885ESR2 2359/4885ALDH1A1 2090/4885 |
| US-20220177497-A1 | CONTINUOUS INDUSTRIAL PRODUCTION METHOD OF HIGH-PURITY BISPHENOL A-BIS(DIPHENYL PHOSPHATE) | ALPP, POF1B, DUSP4 | ESR1 97/4885ESR2 262/4885ALDH1A1 1260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.